Methotrexate Sodium Injectio · #26 of 35 active shortages by FDA posting duration
Brand: METHOTREXATE
FDA lists Methotrexate Sodium Injectio as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Methotrexate Sodium Injection: Active Shortage
Available 21 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Methotrexate Sodium Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
- Package NDC
- 63323-122-50
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 13, 2023
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Rheumatology, Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesaler for inventory
Full Drug Profile
methotrexate
Side effects, interactions, warnings & more
Nearby, Other Methotrexate Shortage Records
Methotrexate Sodium Injection
Fresenius Kabi USA, LLC
Injection
Methotrexate Sodium Injection
Accord Healthcare Inc.
Injection
Methotrexate Sodium Injection
Accord Healthcare Inc.
Injection
Methotrexate Sodium Injection
Teva Pharmaceuticals USA, Inc.
Injection
Methotrexate Sodium Injection
Teva Pharmaceuticals USA, Inc.
Injection
Methotrexate Sodium Injection
Teva Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Check wholesaler for inventory. General shortage guidance lives on the tracker hub.